Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Clinical trial NCT03563248 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03563248
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-10
- Primary completion
- 2022-02-16
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.